| Literature DB >> 24250472 |
Bahram Daraie1, Jalal Pourahmad, Neda Hamidi-Pour, Mir-Jamal Hosseini, Fatemeh Shaki, Masoud Soleimani.
Abstract
Cytotoxicity of depleted uranium, as a byproduct of military has been came to spotlight in recent decades. DU is known as a chemical rather than radioactive hazard and efforts to illustrating its mechanism is undergo, but the precise complete molecular mechanisms are still unclear. Recent studies showed that uranium induces biological changes in many different target tissues, such as the kidney, brain and skin. The aim of this study was to assess the impact of depleted uranium exposure at the cellular level in the human dermal fibroblast primary cells. The human dermal fibroblast primary cells incubated with different concentration (250-750 μM) of depleted uranium. Cytotoxicity and mitochondrial function in this cell lines were determined with the LDH leakage assay and the MTT test respectively. MDA levels were measured for determination of Lipid peroxidation in DU treated cells. Besides glutathione depletion and apoptosis phenotype detection were also assessed to complete the mechanistic screening. Results showed that the cell viability ameliorates in concentration and time dependent manners following in 24, 48 and 72 h incubation with DU. Moreover the significant increase in lipid peroxidation and significant decrease in cellular GSH recorded in DU treated human dermal fibroblast primary cells suggesting the preoxidant effect of uranyl ions. Cytoprotective effects of N-acetylcysteine (NAC) and dramatic decrease of cell viability in buthionin sulfoxamid (BSO) pretreated cells indicated the possibility of a critical role for glutathione system in DU detoxification. Death pattern, in fibroblast cells following DU treatment was varied from apoptosis to necrosis while the time and concentration increased. Since ROS formation is the initiation step for cell apoptosis, the present studies suggest Uranyl-induced toxicity in the human dermal fibroblast primary cells originated from oxidative stress and lead to occurrence of programmed cell death.Entities:
Keywords: Fibroblast; Lipid peroxidation; Oxidative stress; Uranium
Year: 2012 PMID: 24250472 PMCID: PMC3832159
Source DB: PubMed Journal: Iran J Pharm Res ISSN: 1726-6882 Impact factor: 1.696
Mitochondrial function assessment for the human dermal fibroblast primary cells following exposure to uranyl acetate for 24, 48 and 72 h based on the dose-response curves as derived from the MTT assay. Succcinate dehydrogenase activity inhibited by U in a dose- and time-dependent manner (*p < 0.05).
|
|
| ||
|---|---|---|---|
|
|
|
| |
| Control | 0 ± 3 | 3 ± 4 | 4 ± 6 |
| U (250 µM) | *12 ± 4 | 34 ± 5* | 43 ± 5* |
| U (500 µM) | 23 ± 8* | 48 ± 9* | 59 ± 8* |
| U (750 µM) | 31 ± 3* | 52 ± 6* | 82 ± 5* |
Data represent the means of three separate experiments (±SD).
*p < 0.05, significantly different when compared with control.
TBARs level in the human dermal fibroblast primary cells at different concentration and times after uranyl acetate exposure
|
|
| ||
|---|---|---|---|
|
| |||
|
|
|
| |
| Control | 3.26 ± 0.2 | 3.21 ± 0.1 | 3.41 ± 0.1 |
| U (250 µM) | 3.59 ± 0.1 | 5.7 ± 0.17* | 12.55 ± 0.38* |
| U (500 µM) | 4.13 ± 0.12 | 6.9 ± 0.21* | 19.33 ± 0.59* |
| U (750 µM) | 4.87 ± 0.15 | 8.96 ± 0.2* | 32.86 ± 1.01* |
Data represent the means of three separate experiments (±SD).*p < 0.05, significantly different when compared with control
Effect of uranyl acetate on mitochondrial function (suucinate dehydrogenase activity) in the human dermal fibroblast primary cells for 24, 48 and 72 h
|
|
| ||
|---|---|---|---|
|
|
|
| |
| Control | 0 | 2 ± 1 | 3 ± 1 |
| U(250 µM) | 9 ± 5 | 30 ± 7* | 40 ± 6* |
| U(500 µM) | 21 ± 3* | 43 ± 8* | 54 ± 5* |
| U(750 µM) | 27 ± 7* | 49± 6* | 76 ± 9* |
| NAC + U(750 µM) | 0 ± 6† | 46 ± 3 | 59 ± 9† |
Data represent the means of three separate experiments (±SD).
*p < 0.05, significantly different when compared with control.
†p < 0.05, significantly different when compared with U (750 µM)
Effect of Uranyl acetate on apoptosis and necrosis phenotype in the human dermal fibroblast primary cells at different times
|
|
| ||||||||
|---|---|---|---|---|---|---|---|---|---|
|
|
|
| |||||||
|
|
|
|
|
|
|
|
|
| |
| Control | 0 | 0 | 0 | 3 | 97 ± 1 | 3 ± 1 | 8 | 93 ± 3 | 7 ± 2 |
| U (250 µM) | 11 | 98 ± 5 | 2 ± 0 | 30 | 82± 3* | 18 ± 2* | 42 | 74 ± 3* | 26 ± 2* |
| U (500 µM) | 20 | 92 ± 3 | 8 ± 1* | 45 | 80 ± 1* | 20 ± 1* | 54 | 52 ± 2* | 48 ± 1* |
| U (750 µM) | 32 | 89 ± 3 | 11 ± 3* | 48 | 73 ± 4* | 27 ± 3* | 72 | 20 ± 1* | 80 ± 1* |
A: Apoptosis, N: Necrosis. Data represent the means of three separate experiments (±SD).
*Significant difference in comparison with control cells (p < 0.05).
Effect of Uranyl acetate on GSH level in the human dermal fibroblast primary cells at different times
|
|
| ||
|---|---|---|---|
|
| |||
|
|
|
| |
| Control | 2.01 ± 0.04 | 2. ± 0.01 | 2 ± 0.01 |
| U (250 µM) | 1.81 ± 0.05* | 1.41 ± 0.07* | 0.69 ± 0.02* |
| U (500 µM) | 1.7 ± 0.06* | 1.16 ± 0.05* | 0.44 ± 0.01* |
| U (750 µM) | 1.48 ± 0.05* | 0.98 ± 0.03* | 0.3 ± 0.01* |
Data represent the means of three separate experiments (±SD).
*Significant difference in comparison with control cells (p < 0.05).